Matches in Wikidata for { <http://www.wikidata.org/entity/Q94132432> ?p ?o ?g. }
- Q94132432 description "2019 nî lūn-bûn" @default.
- Q94132432 description "2019年の論文" @default.
- Q94132432 description "2019年学术文章" @default.
- Q94132432 description "2019年学术文章" @default.
- Q94132432 description "2019年学术文章" @default.
- Q94132432 description "2019年学术文章" @default.
- Q94132432 description "2019年学术文章" @default.
- Q94132432 description "2019年学术文章" @default.
- Q94132432 description "2019年學術文章" @default.
- Q94132432 description "2019年學術文章" @default.
- Q94132432 description "2019年學術文章" @default.
- Q94132432 description "2019年學術文章" @default.
- Q94132432 description "2019年學術文章" @default.
- Q94132432 description "2019년 논문" @default.
- Q94132432 description "article científic" @default.
- Q94132432 description "article scientific" @default.
- Q94132432 description "article scientifique" @default.
- Q94132432 description "articol științific" @default.
- Q94132432 description "articolo scientifico" @default.
- Q94132432 description "artigo científico" @default.
- Q94132432 description "artigo científico" @default.
- Q94132432 description "artigo científico" @default.
- Q94132432 description "artikel ilmiah" @default.
- Q94132432 description "artikull shkencor" @default.
- Q94132432 description "artikulong pang-agham" @default.
- Q94132432 description "artykuł naukowy" @default.
- Q94132432 description "artículo científico publicado en 2019" @default.
- Q94132432 description "artículu científicu" @default.
- Q94132432 description "bilimsel makale" @default.
- Q94132432 description "bài báo khoa học" @default.
- Q94132432 description "naučni članak" @default.
- Q94132432 description "scienca artikolo" @default.
- Q94132432 description "scientific article published on 23 October 2019" @default.
- Q94132432 description "scientific article published on 23 October 2019" @default.
- Q94132432 description "scientific article published on 23 October 2019" @default.
- Q94132432 description "teaduslik artikkel" @default.
- Q94132432 description "tieteellinen artikkeli" @default.
- Q94132432 description "tudományos cikk" @default.
- Q94132432 description "vedecký článok" @default.
- Q94132432 description "vetenskaplig artikel" @default.
- Q94132432 description "videnskabelig artikel udgivet 23. oktober 2019" @default.
- Q94132432 description "vitenskapelig artikkel" @default.
- Q94132432 description "vitskapeleg artikkel" @default.
- Q94132432 description "vědecký článek" @default.
- Q94132432 description "wetenschappelijk artikel" @default.
- Q94132432 description "wissenschaftlicher Artikel" @default.
- Q94132432 description "επιστημονικό άρθρο" @default.
- Q94132432 description "мақолаи илмӣ" @default.
- Q94132432 description "наукова стаття, опублікована в жовтні 2019" @default.
- Q94132432 description "научна статия" @default.
- Q94132432 description "научная статья" @default.
- Q94132432 description "научни чланак" @default.
- Q94132432 description "научни чланак" @default.
- Q94132432 description "գիտական հոդված հրատարակված 2019 թվականի հոկտեմբերի 23-ին" @default.
- Q94132432 description "מאמר מדעי" @default.
- Q94132432 description "مقالة علمية نشرت في 23 أكتوبر 2019" @default.
- Q94132432 description "২৩ অক্টোবর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q94132432 description "บทความทางวิทยาศาสตร์" @default.
- Q94132432 description "სამეცნიერო სტატია" @default.
- Q94132432 name "2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study" @default.
- Q94132432 name "2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study" @default.
- Q94132432 type Item @default.
- Q94132432 label "2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study" @default.
- Q94132432 label "2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study" @default.
- Q94132432 prefLabel "2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study" @default.
- Q94132432 prefLabel "2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study" @default.
- Q94132432 P1433 Q94132432-F2EF2793-287D-44F2-A690-A21C84408748 @default.
- Q94132432 P1476 Q94132432-DD062C2C-1943-4669-9613-F749A9D549F5 @default.
- Q94132432 P2093 Q94132432-0EF84058-E1D9-40CF-B4CD-7AD43F1D540F @default.
- Q94132432 P2093 Q94132432-58F805B4-3AB4-4373-A9C9-A86C3230D634 @default.
- Q94132432 P2093 Q94132432-6217785F-ED23-48F3-AD45-065844320D61 @default.
- Q94132432 P2093 Q94132432-87D9B9E7-3A00-4E72-B047-C42FB3087C3D @default.
- Q94132432 P2093 Q94132432-9CE91716-016B-4803-A811-9C98FD41827D @default.
- Q94132432 P2093 Q94132432-B44C2093-EA7C-4C17-83C5-73C49187417F @default.
- Q94132432 P2093 Q94132432-B6797AA4-E939-42AA-90B6-5DA561E4A143 @default.
- Q94132432 P2093 Q94132432-FD7140AD-D698-4853-8A07-32941226FEE9 @default.
- Q94132432 P275 Q94132432-f195b6a4-ee86-4a3f-ae28-40a7e957bee5 @default.
- Q94132432 P304 Q94132432-A975FA56-C3F8-432B-9D92-C0CBE7ADD53B @default.
- Q94132432 P31 Q94132432-1DF34E25-AB83-43E9-A228-BFB68D52FAA7 @default.
- Q94132432 P356 Q94132432-083B9CEC-2027-46F8-A35A-C3971BABB7EC @default.
- Q94132432 P433 Q94132432-1150F5C4-FC73-4341-A0AF-082B95382A76 @default.
- Q94132432 P478 Q94132432-15CFED8E-B0D7-4EF1-A857-5FDFBC275A52 @default.
- Q94132432 P577 Q94132432-58599E44-D545-4AB5-8BDD-F5FF5145FE6C @default.
- Q94132432 P6216 Q94132432-68c00b52-52b3-404a-aeca-833db7862d8d @default.
- Q94132432 P921 Q94132432-53241C37-99D6-44B0-A660-E662350ABC39 @default.
- Q94132432 P921 Q94132432-A9C367D3-D171-4DE3-912F-16CA0ACCFCEC @default.
- Q94132432 P932 Q94132432-61A9D7FA-22BC-4DB2-A910-D61DA98C0E21 @default.
- Q94132432 P356 OFZ360.1923 @default.
- Q94132432 P1433 Q27725953 @default.
- Q94132432 P1476 "2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study" @default.
- Q94132432 P2093 "Andrew Meads" @default.
- Q94132432 P2093 "Christian Sandrock" @default.
- Q94132432 P2093 "David Fitts" @default.
- Q94132432 P2093 "David Mariano" @default.
- Q94132432 P2093 "Elizabeth Alexander" @default.
- Q94132432 P2093 "Gregory J Moran" @default.
- Q94132432 P2093 "Jennifer Schranz" @default.
- Q94132432 P2093 "Steven P Gelone" @default.
- Q94132432 P275 Q24082749 @default.
- Q94132432 P304 "S767-S768" @default.